Skaar, who directs the Vanderbilt Institute for Infection, Immunology and Inflammation, is being recognized for “pioneering work at the intersection of nutrition and infectious diseases."

Previous studies suggested that fostamatinib may suppress inflammatory responses triggered by COVID-19 and mitigate ongoing lung injury, decreasing mortality and oxygen requirements.

To reduce your risk of becoming ill and to create a safe environment for our coworkers and patients, a reminder of these essential infection prevention precautions

A 17-year-old cystic fibrosis warrior and liver transplant recipient with antibiotic resistance got to see science in action at Vanderbilt Medical Laboratories.

The project aims to design computational “tool kits” that can speed development of multi-virus vaccines targeting some of the greatest infectious threats to human health.

The study findings point to the potential of interleukin-13 antibodies — approved for use in humans — as a treatment to protect against bacterial pneumonia in patients with zinc deficiency.

While it has been difficult to pinpoint the reason for the rise in cases, waning immunity and vaccine hesitancy may be the likely culprits.